Silence Therapeutics PLC (SLN)
23.40
+0.40
(+1.74%)
USD |
NASDAQ |
May 20, 14:31
Silence Therapeutics Price to Book Value: 50.22 for May 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 49.36 |
| May 16, 2024 | 49.23 |
| May 15, 2024 | 47.92 |
| May 14, 2024 | 45.37 |
| May 13, 2024 | 44.68 |
| May 10, 2024 | 45.52 |
| May 09, 2024 | 49.26 |
| May 08, 2024 | 48.50 |
| May 07, 2024 | 47.62 |
| May 06, 2024 | 47.00 |
| May 03, 2024 | 47.19 |
| May 02, 2024 | 45.71 |
| May 01, 2024 | 45.97 |
| April 30, 2024 | 46.92 |
| April 29, 2024 | 46.96 |
| April 26, 2024 | 46.37 |
| April 25, 2024 | 46.40 |
| April 24, 2024 | 47.80 |
| April 23, 2024 | 48.31 |
| April 22, 2024 | 48.29 |
| April 19, 2024 | 48.59 |
| April 18, 2024 | 47.26 |
| April 17, 2024 | 46.27 |
| April 16, 2024 | 45.61 |
| April 15, 2024 | 44.34 |
| Date | Value |
|---|---|
| April 12, 2024 | 47.58 |
| April 11, 2024 | 47.99 |
| April 10, 2024 | 45.28 |
| April 09, 2024 | 44.96 |
| April 08, 2024 | 45.84 |
| April 05, 2024 | 45.28 |
| April 04, 2024 | 45.86 |
| April 03, 2024 | 45.65 |
| April 02, 2024 | 45.47 |
| April 01, 2024 | 46.46 |
| March 28, 2024 | 46.25 |
| March 27, 2024 | 46.72 |
| March 26, 2024 | 46.22 |
| March 25, 2024 | 46.80 |
| March 22, 2024 | 46.95 |
| March 21, 2024 | 48.58 |
| March 20, 2024 | 49.05 |
| March 19, 2024 | 49.97 |
| March 18, 2024 | 51.41 |
| March 15, 2024 | 48.90 |
| March 14, 2024 | 51.02 |
| March 13, 2024 | 54.83 |
| March 12, 2024 | 55.45 |
| March 11, 2024 | 51.92 |
| March 08, 2024 | 54.79 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
8.081
Minimum
Apr 24 2023
111.35
Maximum
Apr 01 2022
34.55
Average
29.73
Median
Oct 14 2021
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 11.27 |
| NuCana PLC | 0.4025 |
| TC BioPharm (Holdings) PLC | 1.037 |
| Biodexa Pharmaceuticals Plc | 0.9713 |
| Autolus Therapeutics PLC | 9.661 |
Price to Book Value Related Metrics
| PS Ratio | 27.67 |
| Price | 23.40 |
| Earnings Yield | -6.21% |
| Market Cap | 1.091B |